Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$200.97 USD
-0.96 (-0.48%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $200.78 -0.19 (-0.09%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth A Momentum C VGM
Price, Consensus and EPS Surprise
CRL 200.97 -0.96(-0.48%)
Will CRL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CRL
Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down
Here's What Key Metrics Tell Us About Charles River (CRL) Q2 Earnings
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Charles River Laboratories (CRL) Surpasses Q2 Earnings and Revenue Estimates
Unlocking Q2 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics
Here's How Charles River (CRL) is Placed Ahead of Q2 Earnings
Other News for CRL
Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)
Wall Street Breakfast: What Moved Markets
UK shareholder meetings calendar - next 21 days
ClearBridge Mid Cap Growth Strategy Q2 2024 Commentary
ClearBridge All Cap Growth Strategy Q2 2024 Commentary